Brief: CorMedix Announces US Inpatient Commercial Availability Of DefenCath
15/04/2024 13:38
April 15 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC. ANNOUNCES U.S. INPATIENT COMMERCIAL
AVAILABILITY
OF DEFENCATH® (TAUROLIDINE AND HEPARIN)
Source text for Eikon: ID:nGNX3KfPz9
Further company coverage: CRMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary